Quo vadis with targeted drugs in the 21st century?
- PMID: 19047306
- DOI: 10.1200/JCO.2008.18.8342
Quo vadis with targeted drugs in the 21st century?
Similar articles
-
[Sorafenib].Dtsch Med Wochenschr. 2010 Sep;135(37):1819-22. doi: 10.1055/s-0030-1247869. Epub 2010 Aug 20. Dtsch Med Wochenschr. 2010. PMID: 20730706 German. No abstract available.
-
Population differences in the use of EGFR-targeted agents.Clin Adv Hematol Oncol. 2008 Oct;6(10):730-2. Clin Adv Hematol Oncol. 2008. PMID: 18997662 No abstract available.
-
Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy.Melanoma Res. 2008 Apr;18(2):161-2. doi: 10.1097/CMR.0b013e3282f3d117. Melanoma Res. 2008. PMID: 18337654
-
Therapeutic strategies for triple-negative breast cancer.Cancer J. 2008 Nov-Dec;14(6):343-51. doi: 10.1097/PPO.0b013e31818d839b. Cancer J. 2008. PMID: 19060597 Review.
-
Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.Anticancer Res. 2009 Mar;29(3):823-30. Anticancer Res. 2009. PMID: 19414315 Review.
Cited by
-
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer.Mol Oncol. 2015 Aug;9(7):1384-91. doi: 10.1016/j.molonc.2015.03.011. Epub 2015 Apr 3. Mol Oncol. 2015. PMID: 25888067 Free PMC article. Clinical Trial.
-
Hurdles in anticancer drug development from a regulatory perspective.Nat Rev Clin Oncol. 2012 Feb 21;9(4):236-43. doi: 10.1038/nrclinonc.2012.14. Nat Rev Clin Oncol. 2012. PMID: 22349015 Review.
-
A new vision of photothermal therapy assisted with gold nanorods for the treatment of mammary cancers in adult female rats.Nanoscale Adv. 2023 Dec 4;6(1):170-187. doi: 10.1039/d3na00595j. eCollection 2023 Dec 19. Nanoscale Adv. 2023. PMID: 38125593 Free PMC article.
-
Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care.J Clin Med. 2020 Jun 24;9(6):1984. doi: 10.3390/jcm9061984. J Clin Med. 2020. PMID: 32599960 Free PMC article.
-
Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model.Int J Nanomedicine. 2013;8:4247-63. doi: 10.2147/IJN.S51070. Epub 2013 Nov 6. Int J Nanomedicine. 2013. PMID: 24232189 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous